Leumi Partners, the Investment arm of Bank Leumi, one of Israel’s two largest banks, has led a $150 million round for a medtech investment fund led by former Israeli healthcare system officials, several people connected to the fund who spoke on condition of anonymity told Calcalist. According to the people, Leumi Partners invested $10 million in the new fund, called ALIVE HealthTech Fund, and is one of four anchor investors who invested a total of $50 million.

The three other anchor investors in the fund, announced last year, are Maccabi Fund, which is associated with the Israeli health maintenance organization (HMO) Maccabi Healthcare Service, British-Iranian entrepreneur Vincent Tchenguiz, through his investment firm Consensus Business Group (CBG), and not-for-profit Virginia and West Virginia healthcare organization Carilion Clinics.

Heading ALIVE are Rafael Beyar, an Israeli medical doctor who served as the director-general and CEO of the Rambam Health Care Campus in Haifa (Rambam Hospital) between 2006 and 2019; Ari Shamiss, formerly the director of the general hospital at Sheba Medical Center in central Israel and former CEO of Israeli private hospital chain Assuta Medical Centers; and Michel Habib, formerly the CEO of Tel Aviv-listed medtech investment company Hadasit Bio-Holdings Ltd., in which CBG is a stakeholder.